The Genitourinary Cancer Program at Cancer Treatment Centers of America® (CTCA), Philadelphia, uses evidence-based treatments and a wide range of sophisticated technologies to treat early-stage and advanced-stage genitourinary (GU) cancers. These diseases include:
- Cancers of the male reproductive system, such as prostate and testicular cancers
- Cancers of the urinary tract, including bladder and kidney cancers, in both men and women
- Other rare, complex and common cancers
Our multidisciplinary team of urologists and urologic oncologists work with a staff of medical, surgical and radiation oncologists, along with our gastroenterologists and interventional radiologists, and supportive care providers to deliver quality clinical care with a patient-centered approach.
Genitourinary cancer treatment
Treatment for a genitourinary cancer typically depends on a number of factors, such as the type of cancer, its stage, a patient’s overall health and potential side effects, including the treatment’s impact on fertility and sexual wellness. Our team of experts and specialists work together under one roof to develop a treatment plan tailored to your needs. At CTCA®, we’re committed to helping you make informed decisions about the options available to treat and manage your disease.
Treatment options may include:
Meet our Genitourinary Cancer Program team
The doctors and other clinicians on the Genitourinary Cancer Program team at CTCA Philadelphia are committed to offering comprehensive treatments for patients diagnosed with cancers of the urinary tract and male reproductive system. The Genitourinary Cancer Program team at CTCA Philadelphia is committed to a multidisciplinary approach to care. After you receive a diagnosis, you will work together with a team of experts assembled based on your individual needs and goals, to develop a treatment plan tailored specifically to you.
Explore the links below to learn more about the team.
Integrative cancer care
As a patient at the Genitourinary Cancer Program, you will be cared for by a team of experts who also work closely with supportive care providers to help manage additional disease- and treatment-related symptoms and side effects, such as nausea, vomiting, pain, and sex and intimacy challenges. Supportive care services may include:
Sexual wellness
More than half of those living with GU cancer will experience some form of sexual dysfunction, changes in their sexual desire or other concerns about intimacy. Patients with any type of cancer may experience sexual dysfunction, but those with genitourinary cancers are especially at risk for symptoms and side effects that affect sexual health. The CTCA Philadelphia Genitourinary Cancer Program team includes experts trained in helping patients address physical and psychological challenges that may cause sexual dysfunction. These challenges include:
- Anxiety and depression
- Fatigue
- Low libido
- Vaginal scarring, tightness and/or dryness
- Erectile dysfunction
- Painful intercourse
- Peyronie’s disease
These side effects of cancer treatment may often involve difficult decisions and conversations. Your care team at CTCA will work together and with you to develop a plan intended to help prevent or manage sexual side effects, so you can maintain healthier relationships and improve your quality of life.
Pelvic floor physical therapy
Genitourinary cancers and treatments may weaken or damage the pelvic floor. This group of muscles at the bottom of the pelvis help to support and control the bladder, bowel and sexual function. Among the side effects of pelvic floor dysfunction are:
- Leakage of urine or stool
- Constipation
- Painful bowel movements or urination
- Painful intercourse for women
- Lower back pain
At CTCA Philadelphia, our physical therapists are trained in the evaluation and treatment of pelvic floor dysfunction. Physical therapy programs designed to strengthen the pelvic floor muscles may help relieve the side effects of cancer treatment and help to improve your quality of life.
Learn more about pelvic floor therapy.
Clinical trials
Cancer clinical trials are a key testing ground for determining the safety and effectiveness of new drugs and other treatments for many types of cancer.
The oncologists and other physicians working with patients at the Genitourinary Cancer Program at CTCA Philadelphia are committed to providing innovative treatments for their patients whenever possible. This includes enrolling qualified patients in carefully selected clinical trials. Although clinical trials are not available to all patients, they may offer some patients options that would otherwise be unavailable to them.
As part of that commitment, our oncologists may recommend that cancer patients who meet specific criteria enroll in one of our ongoing cancer clinical trials. Your care team will work with you to determine whether you qualify for any of these studies or those offered at a national level, and if so, help you enroll.
Where we are located
CTCA Philadelphia
Genitourinary Cancer Program1331 E. Wyoming Ave.
Philadelphia, PA 19124
New Patients: 888-552-6760
Existing Patients: (215) 607-CTCA
